DEF: NanoVibronix Seeks Stockholder Approval for Reverse Stock Split and Share Issuance to Maintain Nasdaq Listing

NanoVibronix is holding a special meeting to seek stockholder approval for a reverse stock split and the issuance of shares related to a warrant exchange, aiming to maintain its Nasdaq listing.

Summary

• NanoVibronix is holding a special virtual meeting on February 24, 2025, to vote on three key proposals.
• The first proposal is to approve a reverse stock split of the company's common stock at a ratio between 1-for-2 and 1-for-11, to be determined by the Board of Directors.
• The second proposal seeks approval for the issuance of common stock underlying certain warrants issued in a Securities Exchange Agreement, which could exceed 20% of the outstanding shares.
• The third proposal is to allow the meeting to be adjourned if necessary to gather more votes.
• The reverse stock split is required to meet Nasdaq's minimum bid price requirement of $1.00 per share, a condition for a limited extension to maintain the company's listing.
• The company received a delisting notice from Nasdaq due to not meeting the minimum bid price and stockholders equity requirements.
• The board has been granted a limited extension to regain compliance, which includes completing the reverse stock split by March 31, 2025, and maintaining a $1.00 closing bid price for at least ten consecutive trading days.
• The company has 6,138,028 shares of common stock outstanding as of January 17, 2025.
• The reverse stock split will reduce the number of outstanding shares, but the percentage ownership of each stockholder will remain approximately the same, except for fractional shares which will be rounded up to the next whole share.
• The company entered into a Securities Exchange Agreement on January 7, 2025, to exchange an existing warrant for new shares and warrants, including a common warrant to purchase up to 1,744,186 shares.
• The issuance of shares underlying the common warrant requires stockholder approval under Nasdaq rules because it could exceed 20% of the outstanding shares and the price is less than the Nasdaq Minimum Price.
• The company has engaged a proxy solicitation firm at an approximate cost of $30,000, plus reimbursement expenses.

Sentiment

Score: 4

Explanation: The document indicates a company facing significant challenges with its stock price and Nasdaq listing. While the company is taking steps to address these issues, the overall tone is cautious and reflects a difficult situation.

Positives

• The reverse stock split aims to increase the share price to meet Nasdaq's listing requirements.
• The company has secured a limited extension from Nasdaq to regain compliance.
• The exchange of warrants removes unfavorable terms that could hinder future transactions.
• The company is actively seeking to maintain its Nasdaq listing, which is important for investor confidence and access to capital.

Negatives

• The reverse stock split may not increase the share price long-term and could decrease liquidity.
• The company is currently not in compliance with Nasdaq listing requirements.
• The issuance of new shares could dilute existing stockholders' ownership.
• The company may be delisted from Nasdaq if it fails to meet the conditions of the extension.

Risks

• The reverse stock split may not increase the stock price or maintain it above $1.00.
• The company could be delisted from Nasdaq if it fails to meet the listing requirements.
• Delisting could reduce the liquidity of the stock and make it harder to raise capital.
• The issuance of new shares could dilute existing stockholders' ownership and potentially decrease the stock price.
• The reverse stock split could lead to some stockholders owning odd lots, which may be more difficult to sell.

Future Outlook

The company aims to regain compliance with Nasdaq listing requirements by completing the reverse stock split and maintaining a minimum share price. The company may need to raise additional capital in the future.

Management Comments

• Brian Murphy, Chief Executive Officer, urges stockholders to vote as soon as possible.
• The Board recommends a vote FOR the Reverse Stock Split Proposal, the Issuance Proposal and the Adjournment Proposal.

Industry Context

Companies facing delisting from major exchanges often resort to reverse stock splits to artificially inflate their share price and meet minimum listing requirements. This is a common strategy in the biotech and small-cap sectors where stock prices can be volatile.

Comparison to Industry Standards

• Reverse stock splits are a common tactic for companies facing delisting from exchanges like Nasdaq, similar to actions taken by other small-cap and biotech firms.
• The range of the proposed reverse stock split (1-for-2 to 1-for-11) is within the typical range seen in similar situations.
• The need for shareholder approval for the issuance of shares related to warrants is standard practice under Nasdaq rules, similar to other listed companies.
• The company's situation is comparable to other companies that have received delisting notices and are seeking extensions to regain compliance.

Stakeholder Impact

• Shareholders face potential dilution and the risk of a decrease in stock value.
• Employees may be concerned about the company's financial stability and future prospects.
• Customers and suppliers may be impacted by the company's financial situation and potential delisting.
• Creditors may be concerned about the company's ability to repay debts.

Next Steps

• Stockholders need to vote on the proposals by February 23, 2025.
• The Board will determine the specific ratio for the reverse stock split if approved.
• The company will file the reverse stock split amendment with the Secretary of State of Delaware if approved.
• The company needs to maintain a $1.00 closing bid price for at least ten consecutive trading days after the reverse stock split.
• The company needs to demonstrate compliance with the Equity Rule by March 31, 2025.

Key Dates

Keywords

reverse stock split, Nasdaq listing, share issuance, warrants, stockholder meeting, delisting, compliance, proxy, common stock